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Case Reports & Case Series
Spontaneous intracranial hypotension complicated by refractory subdural
hematomas in a patient with coagulation factor XIII deﬁciency
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A B S T R A C T
Spontaneous intracranial hypotension (SIH) is often secondary to an occult cerebrospinal ﬂuid (CSF) leak in the
neuroaxis. It is sometimes associated with chronic subdural hematomas (SDH). The authors present the case of a
61 year-old male who presented with SIH from an occult CSF leak and complicated by refractory SDH. The
patient underwent treatment for SIH with multiple epidural blood patches, hydration and bed rest. In addition,
he underwent evacuation of his SDH twice, once via burr hole drainage and the second via craniotomy. Once the
diagnosis of coagulation factor XIII (CFXIII) deﬁciency was made, the patient was treated with recombinant
factor XIII followed by an epidural blood patch. He subsequently made a complete recovery. In this report, the
authors propose management strategies for treating patients with SIH complicated by refractory SDH and
coagulopathies by reviewing the literature.
1. Introduction
Spontaneous intracranial hypotension (SIH) is often secondary to an
occult cerebrospinal ﬂuid (CSF) leak in the neuroaxis. It is sometimes
associated with chronic subdural hematomas (SDH). The combination
of clinical symptoms and neuroimaging should alert the practitioner of
SIH and therefore guide the practitioner to the appropriate treatment
[4,6]. The treatment of choice in this situation is an epidural blood
patch if conservative measures such as bedrest and hydration fail. For
larger SDH, evacuation may be necessary in conjunction with an epi-
dural blood patch. However, refractory subdural hematomas may
complicate the situation despite appropriate management [7]. Coagu-
lation factor XIII (CFXIII) is a clot stabilizing factor in the clotting
cascade and has also been shown to contribute to wound healing by
encouraging the migration and proliferation of ﬁbroblasts into the clot
[1,5]. We present a case of a healthy 61 year-old male who presented
with SIH from an occult CSF leak and complicated by refractory SDH.
He did not respond to treatment until the diagnosis of CFXIII was made
and treated appropriately.
2. Case presentation
A 61 year-old right handed male with no past medical history pre-
sented to our emergency department with 3 days of progressively
worsening headaches. The headaches were severe and positional in
nature. He had a nonfocal neurologic examination. A noncontrast
commuted tomography (CT) of the head showed bilateral hypodense
subdural collections (Fig. 1A). At this point, spontaneous intracranial
hypotension (SIH) as a result of occult cerebrospinal ﬂuid leak (CSF
leak) was suspected based on clinical and radiological exam.
As part of his work-up for an occult CSF leak magnetic resonance
imaging (MRI) of the neuroaxis (brain, cervical, thoracic and lumbar
spine) was obtained which demonstrated several small nerve root
sleeve cysts in the midthoracic region. A CT myelogram was subse-
quently obtained with no further ﬁndings. Since no obvious source of
leak was found, the decision was made to manage him conservatively
with bed rest, intravenous ﬂuids, and caﬀeine pills. His headaches
improved substantially after 2 days and he was discharged home after a
CT demonstrated stability of his subdural collections.
He returned one week later with severe positional headaches. A
follow-up CT scan demonstrated an increase in the size of the subdural
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collections with additional acute blood (Fig. 1B). Although nonfocal on
his initial neurologic exam, he became lethargic despite intravenous
ﬂuids and lying ﬂat for 24 h. The decision was then made to take him to
the operating room and drain the subdural hematomas with bilateral
burr holes. On postoperative day one his symptoms improved and a
postoperative CT demonstrated signiﬁcant reduction in the subdural
ﬂuid collections. However, by the second postoperative day, his
symptoms of severe positional headaches and lethargy recurred. At this
point, a blood patch was performed using 60ml of autologous blood
injected through a spinal needle into the epidural space of the lumbar
spine.
The patient's headaches did not improve after the blood patch. In
addition, he developed word ﬁnding diﬃculties. Due to the new focal
neurologic deﬁcit, a CT scan was performed which showed an increase
in size of the left subdural collection with associated mass eﬀect and
acute blood (Fig. 1C). Due to the reappearance of acute blood in the
subdural collection, a hematology consult was obtained. He was taken
to the operating room for a left sided craniotomy and evacuation of the
subdural hematoma. A postoperative CT demonstrated evacuation of
the hematoma (Fig. 1D) and a second blood patch was performed. The
patient initially improved.
By postoperative day 2, despite being kept ﬂat, he became pro-
gressively obtunded and required intubation. An MRI of the brain de-
monstrated downward displacement of the cerebellar tonsils and
splenium of the corpus callosum with severe crowding of the foramen
magnum. Progressive sulcal, third and fourth ventricle, and basal cis-
tern eﬀacement was seen consistent with severe intracranial hypoten-
sion. The patient was placed in 30 degrees Trendelenberg and within
15min he regained consciousness. At this time, his hematology work-
up revealed a severe coagulation factor XIII deﬁciency, at a level of 23%
in his plasma (normal range, 70–140%). The patient was given re-
combinant factor XIII intravenously followed by a third blood patch. He
subsequently made a complete recovery. A surveillance CT scan was
performed as an outpatient and demonstrated complete resolution of
the subdural collections.
3. Discussion
Spontaneous intracranial hypotension (SIH) should be suspected in
patients with postural headaches. In patients with SDH who have pos-
tural headaches and no history of trauma or coagulopathy, the diag-
nosis and treatment of SIH is critical for a favorable outcome.
Recurrence of SDH associated with SIH is common until treatment of
the underlying CSF leak is achieved [3,7]. There is ample evidence that
epidural blood patch (EBP) alone is eﬀective in treating patients with
chronic SDH associated SIH even when the site of CSF leak has not been
identiﬁed [3]. Repeated EBP may be required in patients. In the rare
refractory patient, surgical repair of a CSF leak is required but is
Fig. 1. Axial CT of the head on presentation (A), 7 days after presentation (B), 4 days after bilateral burr hole drainage (C), and post-craniotomy (D) demonstrating
the subdural hematomas.
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dependent on establishing the site of the leakage [6]. There are reports
that targeted EBP may be more eﬀective in sealing the leak the ﬁrst
time, especially in patients with concomitant SDH, however, they are
associated with a higher complication rate, including spinal cord injury
[9]. Occluding the CSF leak is critical in the treatment of SDH asso-
ciated SIH and therefore may require multiple procedures to accom-
plish this with or without subsequent evacuation of the SDH in neu-
rologically compromised patients.
Nevertheless, some patients may remain refractory to treatment.
There has been an association between coagulopathy and chronic re-
current SDH, particularly in young patients [1,2]. Speciﬁcally, low le-
vels of factor XIII have been associated with recurrent SDH. Coagula-
tion factor XIII (CFXIII) stabilizes ﬁbrin in the clotting cascade and
protects it against ﬁbrinolysis by mechanically cross-linking ﬁbrin
chains and alpha-2 plasmin inhibitor. It is also involved in wound
healing by stabilizing endothelial barrier function and vascular in-
tegrity. Moreover, the pathophysiology of chronic SDH, with the fragile
neovascularization of membranes, can further potentiate decreased
CFXIII levels through a consumptive process, thereby starting a vicious
cycle in patients who are already compromised [1,2,5,8].
In CFXIII deﬁcient patients, with chronic recurrent SDH, treatment
with recombinant CFXIII has been shown to be eﬀective. Furthermore,
CFXIII has been used to treat SIH refractory to treatment, extrapolating
from wound healing properties studied in the literature. In a retro-
spective review, 9 patients with SIH, without SDH, received in-
travenous recombinant CFXIII without complication and favorable
outcomes. All patients had normal CFXIII levels prior to treatment [5].
Although an option, one must consider the high cost of recombinant
CFXIII and the potential serious thrombotic complications that may
occur and should therefore not be used routinely.
CFXIII activity is not routinely assessed on admission in most
medical centers unless there is strong medical suspicion of a coagulo-
pathy. Furthermore, results are obtained 2–3 days after the blood is
drawn, which may delay diagnosis and treatment. Early recognition for
the need to evaluate for CFXIII deﬁciency is critical in patients with
SDH associated SIH. In their series, Shimogawa, et al. retrospectively
Fig. 2. Proposed algorithm for the management of subdural hematoma associated spontaneous intracranial hypotension, which includes proper diagnosis and
treatment of a factor deﬁciency.
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identiﬁed 206 patients who had CFXIII activity data obtained upon
admission to their hospital. Of these patients, they identiﬁed nineteen
SDH associated with SIH patients who necessitated treatment with EBP
with or without SDH evacuation. Seven patients (36.8%) developed
SDH exacerbation post-treatment. This group of patients had sig-
niﬁcantly lower CFXIII activity than those without post-treatment ex-
acerbation. In addition, the CFXIII activity was signiﬁcantly lower in
patients with than without a chronic SDH (42.1% vs. 12.8%). All ﬁve
patients with low CFXIII activity who developed SDH exacerbation
received intravenous recombinant CFXIII and had no recurrence after
this treatment [8].
To our knowledge, there have been no treatment algorithms dis-
cussed in the literature for patients with chronic SDH associated with
SIH and low CFXIII. We report a case of a patient with SDH associated
with SIH and CFXIII deﬁciency. Based on this experience and the lit-
erature, we propose an algorithm for patients who present with SDH
associated SIH in order to prevent delays in diagnosis and treatment, as
well as complications (Fig. 2). If SDH associated with SIH is suspected,
one should conﬁrm SIH with diagnostic images such as MRI of the
neuroaxis, nuclear medicine myelography, or CT myelography. One
should then consider studies to evaluate for a factor deﬁciency if there
is acute blood on imaging. If treatment with an EBP with or without
SDH drainage fails, one should also consider evaluating for a factor
deﬁciency. Early identiﬁcation and treatment in patients with a factor
deﬁciency with intravenous recombinant factors will prevent potential
unnecessary multiple procedures and/or complications.
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